#2 HealthCapital Berlin Brandenburg Reception | Medica 2019
#3 Berlin-Brandenburg Reception | Medica 2022
#4 Meet us at MEDICA 2023
#5 Meet us at MEDICA 2022
#6 Guided Tour for international guests at MEDICA 2019
#7 MEDICA 2019
#8 MEDICA Healthcare Brokerage Event 2021
#9 MEDICA 2018
#10 Medtech & Digital Health
#11 HealthCapital Berlin Brandenburg Reception
#12 COVID-19: Despite the prospect of vaccines, tests are the tool of choice
#13 Diagnostics and Research Tools Digital Partnering Conference
#14 Fraunhofer Institutes for Applied Polymer Research IAP developed 3D printing that enables tissue with customized shape
#15 Revolutionizing the production of novel diagnostics with cost-effective Roll-to-Roll imprinting
#16 9TH ANNUAL HEALTHTECH INVESTMENT FORUM
#17 MIT – Latin America vs. COVID-19
#18 BIO-Europe
#19 22ND ANNUAL BIOTECH IN EUROPE FORUM
#20 Sectors
#21 Health-related Tourism
#22 digital HealthCapital @ conhIT 2018
#23 European Medical Tourism & Global Healthcare Congress
#24 DMEA - Connecting Digital Health
#25 The MedTech Forum & The Global MedTech Compliance Conference
#26 Faster from the laboratory to the patient: Initiative of Fraunhofer, Helmholtz and Hochschulmedizin promotes pilot project in the health sector
#27 NOXXON PHARMA N.V. REPORTS 2017 FINANCIAL RESULTS
#28 Heart Attack and Stroke Risk Also Elevated in Women with Obesity Who Are Metabolically Healthy
#29 MOLOGEN reached key strategic milestones and successfully implements capital measures in 2017
#30 TU Berlin start-up Cellbricks wins World Summit Award
#31 Startups and Pharma in times of DVG – virtual event by Pfizer & APX
#32 sphingotec is adding an advanced POC testing platform to portfolio
#33 MOLOGEN and ONCOLOGIE: Global assignment and codevelopment agreement relating to MOLOGEN’s lead compound lefitolimod
#34 TissUse establishes a liver-endocrine tissues multi-organ model for risk assessment with Bayer
#35 Portrait: 10 Years of The World Health Summit in Berlin
#36 Digital attack on cancer
#37 Call for applicants - Solicit Proposals for Drug Discovery Research
#38 Europe looks to cells for a healthier future
#39 Clovis Oncology Acquires Rights to FAP-Targeted Radiopharmaceutical Program from 3B Pharmaceuticals
#40 Advancing knowledge for the clinical and public health response to the 2019-nCoV epidemic
#41 Digital collaboration on rare diseases
#42 Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats
#43 Aignostics raises €5m Seed Round to advance AI-powered pathology
#44 Berlin Heart: Relief for children with serious coronary diseases
#45 "Germany has done nothing better than other countries, it just acted earlier.”
#46 EU AWARD CELEBRATES IMPACT OF EXCOR® ACTIVE ON CHILDREN WAITING FOR HEART TRANSPLANTATION
#47 GeneQuine Biotherapeutics Secures More Than €9 Million in Series A Financing and Non-Dilutive Funding to Advance Gene Therapy Pipeline for Musculoskeletal Diseases
#48 New cancer-fighting immunotherapy enters clinical trials
#49 Dopavision Closes €12 Million Series A Round to Advance Digital Childhood Myopia Therapeutic Through Clinical Trials
#50 Cystic Fibrosis – Increasing numbers of patients benefit from improved treatment
#51 Lindis Blood Care successfully closes follow-on financing round
#52 Two ERC Consolidator Grants go to MDC researchers
#53 Computational Biology – Shaping medical progress with computer-aided data analysis
#54 Bayer’s BlueRock Therapeutics establishes European site for cell therapy innovation
#55 Ludovic Vallier grows liver tissue from stem cells
#56 Horizon Europe: Charité coordinates four new EU projects
#57 MDC researchers are part of international consortium that discovers how pathogenic gene variants lead to heart failure
#58 Charité study provides evidence to support suspicion that COVID-19 might trigger chronic fatigue syndrome
#59 Aignostics Raises €14m Series A to Advance AI-powered Pathology
#60 Charité researchers win six ERC Starting Grants
#61 Special Topic | Women in the healthcare sector
#62 Innovative research and clinical care under one roof: Rahel Hirsch Center for Translational Medicine of the BIH and Charité opens its doors
#63 Max Delbrück Center discovers mechanism that prevents the human immune response from overshooting
#64 International research team with Charité and Max Planck Institute for Molecular Genetics discover that protein droplets may cause many types of genetic disease
#65 Special Topic | Long COVID in Berlin-Brandenburg – research, networks and engagement for better care
#66 BIO Asia–Taiwan 2020 Online + Live
#67 LIQUID CHROMATOGRAPHY IN SARS-COV-2 RESEARCH
#68 AskBio Receives European Commission Orphan Drug Designation through its EU-Based subsidiary BrainVectis for AB-1003, a Novel Investigational AAV Gene Therapy for the Treatment of Limb-Girdle Muscular Dystrophy (LGMD)
#69 “Turning research into health!” – The Berlin Institute of Health at Charité (BIH) turns 10 years old
#70 Supporting innovation in biomedicine
#71 Nasal vaccine, developed by researchers from Berlin, to prevent COVID-19 passes first tests
#72 Interview | Prof. Dr. Petra Ritter, Head of TEF-Health and Dr. Dirk Schlesinger, Head of TÜV AI Lab
#73 CENTOGENE and Lifera, a Biopharma Company Owned by the PIF, Enter Strategic Collaboration – Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing and Securing CENTOGENE $30 Million Investment
#74 Brandenburg University of Technology Cottbus-Senftenberg have discovered a novel treatment approach for soft tissue tumors
#75 Special Topic | Well-trained professionals in the healthcare industry – The metropolitan region has a lot to offer
#76 ERC Starting Grants for two Charité researchers
#77 Scientists of the MDC-BIMSB have developed a technology to initiate and control organoids’ functioning and interacting
#78 500 Startups Kobe Accelerator for COVID-19 Emerging Technology
#79 RegMed Forum 2020: Viruses and heart diseases
#80 Establishment of the National Center for Tumor Diseases (NCT) Berlin
#81 Special topic | Cardiovascular health in Berlin-Brandenburg
#82 Releasing “brakes” in the brain - Researchers use deep brain stimulation to localize disrupted neural pathways
#83 BIOMEDICA ON THE MOVE
#84 Virtual Partnering Event – Meet with Johnson & Johnson Innovation in Germany
#85 Coffee Break Life Sciences Start-ups | Clinical trials in the medical devices area: tips and tricks for CTA negotiation
#86 Coffee Break Life Sciences Start-ups | Regulatory peculiarities: AI used in medical devices, combination products and companion diagnostics
#87 BIH Digital Health Forum
#88 MIT Covid19 Challenge
#89 German-Polish Dialogue on the Healthcare Sector
#90 AbbVie Partnering Day
#91 Pioneering research: non-invasive brain stimulation with superior accuracy - ERC Consolidator Grant for Charité neuroscientist Surjo Soekadar
#92 Boost for Berlin’s biotech sector
#93 Bayer invests 250 million USD in new cell therapy manufacturing facility in the U.S.
#94 Bayer’s darolutamide plus androgen deprivation therapy (ADT) significantly extends metastasis-free survival with a favorable safety profile compared to placebo plus ADT in non-metastatic castration-resistant prostate cancer
#95 Digital Medicine Week 2021
#96 Matchmaking @ Health Valley Event 2021
#97 Pharmacokinetics - Essentials for project managers in biotech companies
#98 16th Current Topics in Bioinformatics: (Deep) Learning from -OMICS Data?
#99 Protecting your innovation – Workshop on intellectual property and regulatory exclusivity in biotech & pharma
Show more items